In all samples derived from peritoneal fluid, the expression of CD326 and CD45 was examined as epithelial and hematopoietic cell markers, respectively, and the ratio of CD326(+)CD45(-) tumor cells to CD326(-)CD45(+) leukocytes was calculated as the TLR (Figure 1 upper panel). This evidence concerns the gene PTPRC and neoplasm.